BioPharmSignal logoBioPharmSignal

Biotech News

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Sana Biotechnology (SANA)Sana BiotechnologyConference / presentation

SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the BofA Securities 2026 Healthcare Conference at 2:20 p.m.

Open original release

Related news

SANASana Biotechnology2026-01-07 21:26 EST

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

SANASana Biotechnology2026-05-27 20:05 EST

Sana Biotechnology to Present at June 2026 Investor Conferences

CRSPCRISPR Therapeutics2026-05-06 12:30 EST

CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference

SRPTSarepta Therapeutics2026-05-13 20:30 EST

Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

KRYSKrystal Biotech2026-05-07 12:00 EST

Krystal Biotech to Present at BofA Securities 2026 Health Care Conference

CRSPCRISPR Therapeutics2026-04-07 12:00 EST

CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

CRBUCaribou2026-05-05 20:05 EST

Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference

KRYSKrystal Biotech2026-01-05 13:00 EST

Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference

CRBUCaribou2026-05-27 20:05 EST

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

RCKTRocket Pharmaceuticals2026-01-05 12:00 EST

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

View all latest news

Sana Biotechnology

Sana Biotechnology is a cell-engineering company developing engineered cell therapies and in vivo approaches for multiple disease areas. Its ambition is broad, with a platform aimed at reprogramming cells for therapeutic use.

Recent company news

SANASana Biotechnology2026-05-27 20:05 EST

Sana Biotechnology to Present at June 2026 Investor Conferences

SANASana Biotechnology2026-05-15 13:00 EST

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

SANASana Biotechnology2026-05-12 20:05 EST

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

SANASana Biotechnology2026-05-11 20:05 EST

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

SANASana Biotechnology2026-05-05 20:05 EST

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Stock data

Close
3.28 USD
Market cap
901.66M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States